4291 studies found for:    "Sexually Transmitted Diseases, Viral"
Show Display Options
Download search resultsDownload the search results for:
"Sexually Transmitted Diseases, Viral" (4291 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Completed Feasibility of Measuring Immune Resp, Activation in Foreskin/Mucosa in HIV-, Uncircumcised High-HIV-risk MSM, Lima Peru
Conditions: HIV Infections;   Acquired Immunodeficiency Syndrome;   Lentivirus Infections;   Retroviridae Infections;   RNA Virus Infections;   Virus Diseases;   Sexually Transmitted Diseases, Viral;   Sexually Transmitted Diseases;   Immunologic Deficiency Syndromes;   Immune System Diseases;   Slow Virus Diseases
Interventions: Procedure: Circumcision;   Procedure: Flexible sigmoidoscopy
2 Completed Measuring Responses to Sublingual Antigens
Condition: Sexually Transmitted Diseases, Viral
Intervention: Biological: Human Papillomavirus 6,11,16,18 Vaccine Recombinant alum ads
3 Completed Group Therapies for Reducing HIV-risk Behavior in Women Who Have Survived Childhood Sexual Abuse
Conditions: Alcoholism;   Child Abuse, Sexual;   Sexual Abuse;   Sexual Behavior;   Sexually Transmitted Diseases, Viral
Intervention: Behavioral: Trauma-focused group therapy
4 Completed HIV Prevention Intervention for Couples
Condition: Acquired Immunodeficiency Syndrome
Interventions: Behavioral: Couples HIV counseling and testing;   Behavioral: Women's relationship-focused HIV counseling and testing
5 Recruiting Early cART and cART in Combination With Autologous HIV-1 Specific Cytotoxic T Lymphocyte (CTL) Infusion in The Treatment of Acute HIV-1 Infected Adults
Condition: Acute HIV Infection
Interventions: Drug: cART(TDF/AZT+3TC+LPV/r);   Procedure: CTL infusion
6 Completed Safety and Effect of The HDAC Inhibitor Panobinostat on HIV-1 Expression in Patients on Suppressive HAART
Condition: HIV Infection
Intervention: Drug: Panobinostat
7 Completed
Has Results
Human Papillomavirus (HPV) Types Present in External Genital Warts (EGW) in the Argentinean Population
Condition: Condylomata Acuminata
Intervention:
8 Terminated The Mochudi Prevention Project ART Protocol
Condition: HIV Infections
Intervention: Drug: highly active antiretroviral therapy: Lopinavir/Ritonavir, Lamivudine, Zidovudine, Efavirenz, Tenofovir Disoproxil Fumarate, Emtricitabine
9 Terminated A Study to Assess the Long-term Efficacy (24 Weeks) of MPC-4326 in Combination With a 2-3 Drug OBR Relative to the Efficacy of a 3-4 Drug ARV Regimen in Treatment Experienced HIV-1 Infected Subjects Who Are Failing Current Antiretroviral Therapy
Condition: HIV Infections
Interventions: Drug: MPC-4326 plus a 2-3 drug optimized background regimen (OBR);   Drug: 3-4 commercially available antiretroviral drugs
10 Not yet recruiting Safety and Efficacy of Emtricitabine and Tenofovir Alafenamide (F/TAF) Fixed-Dose Combination Once Daily for Pre-Exposure Prophylaxis in Men and Transgender Women Who Have Sex With Men and Are At Risk of HIV-1 Infection
Condition: Pre-Exposure Prophylaxis of HIV-1 Infection
Interventions: Drug: F/TAF;   Drug: F/TDF;   Drug: F/TAF Placebo;   Drug: F/TDF Placebo
11 Not yet recruiting Development of a Tailored HIV Prevention Intervention for Young Men
Condition: HIV Infections
Interventions: Behavioral: myDEx;   Behavioral: NTHP
12 Not yet recruiting High Intensity Lipid Lowering Following Acute Coronary Syndromes for Persons Living With HIV
Conditions: HIV Infection;   Coronary Heart Disease
Interventions: Drug: Pravastatin;   Drug: Rosuvastatin
13 Not yet recruiting Safety and Efficacy Study of Type 2 Herpes Simplex Virus Therapeutic DNA Vaccine
Condition: Herpes Genitalis
Interventions: Biological: VCL-HB01;   Biological: Phosphate-buffered saline
14 Not yet recruiting Safety, Tolerability & Efficacy on LDL-C of Evolocumab in Subjects With HIV & Hyperlipidemia/Mixed Dyslipidemia
Condition: Subjects With Hyperlipidemia, Dyslipidemia and HIV Infection
Interventions: Drug: Repatha (Evolocumab);   Drug: Placebo
15 Not yet recruiting The Peer Support Intervention - Supporting HIV Positive Adolescents in Zimbabwe to Improve HIV Care Continuum Outcomes
Condition: HIV
Intervention: Behavioral: Peer Support
16 Not yet recruiting Gemini 2: An Efficacy, Safety, and Tolerability Study Comparing Dolutegravir (DTG) Plus Lamivudine (3TC) With Dolutegravir Plus Tenofovir/Emtricitabine in Treatment naïve HIV Infected Subjects
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: Dolutegravir (DTG);   Drug: Lamivudine (3TC);   Drug: Tenofovir disoproxil fumarate/Emtricitabine (TDF/FTC FDC)
17 Not yet recruiting Gemini 1: An Efficacy, Safety, and Tolerability Study Comparing Dolutegravir Plus Lamivudine With Dolutegravir Plus Tenofovir/Emtricitabine in Treatment naïve HIV Infected Subjects
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: Dolutegravir (DTG);   Drug: Lamivudine (3TC);   Drug: Tenofovir disoproxil fumarate/Emtricitabine (TDF/FTC FDC)
18 Not yet recruiting Zambian Peer-Educators for HIV Self-Testing Study
Condition: HIV Infection
Intervention: Other: Oral HIV Self-Testing
19 Recruiting 3BNC117 and 10-1074 in HIV-infected Individuals
Condition: Human Immunodeficiency Virus (HIV)
Interventions: Drug: 3BNC117;   Drug: 10-1074;   Other: Analytical treatment interruption;   Drug: Placebo
20 Recruiting 3BNC117 and 10-1074 in HIV Uninfected Adults
Condition: Human Immunodeficiency Virus
Interventions: Drug: 3BNC117;   Drug: 10-1074;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years